CD93 has been previously described as an immature marker on a rare CD34− population of human HSCs, which have self-renewal and repopulating capacities [36], and on AML LSCs [18, 37], most specifically on MLL-rearranged AML. The gene discussed is KMT2A; the disease is acute myeloid leukemia.